Loop Diuretic Therapy in Severe Aortic Stenosis: Marker or Mediator of Adverse Outcomes?

Masaki Miyazawa; Teruhiko Imamura

PMC · DOI:10.1002/clc.70264·January 23, 2026

Loop Diuretic Therapy in Severe Aortic Stenosis: Marker or Mediator of Adverse Outcomes?

Masaki Miyazawa, Teruhiko Imamura

PDF

Open Access

Abstract

Linked entities

Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.

Species1

Homo sapiens(human · species)

Chemicals1

LDT

Diseases8

AS cardiac remodeling congestion LDT heart failure pulmonary congestion renal dysfunction cardiac damage

Peer Reviews

No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.

Videos

No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.

Taxonomy

TopicsCardiac Valve Diseases and Treatments · Cardiovascular Function and Risk Factors · Aortic Disease and Treatment Approaches